Vimarsana
Biggest News Aggregation in the World

Sosei Heptares News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Sosei Heptares. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Sosei Heptares Today - Breaking & Trending Today

Nxera Pharma and PrecisionLife Expand Strategic R&D Partnership into New Therapeutic Area - Vimarsana News

Nxera Pharma and PrecisionLife Expand Strategic R&D Partnership into New Therapeutic Area

Expansion of existing partnership will utilize novel insights into causal biology within auto-immune disorders to identify novel targets for drug ...

Idorsia Pharmaceuticals Ltd: Idorsia announces financial results for the first quarter 2024 - advancing the company with renewed vigor - Vimarsana News

Idorsia Pharmaceuticals Ltd: Idorsia announces financial results for the first quarter 2024 - advancing the company with renewed vigor

Ad hoc announcement pursuant to Art. 53 LR Allschwil, Switzerland - May 21, 2024 Idorsia Ltd (SIX: IDIA) today announced its financial results for the first quarter of 2024. Business highlights Viatris

Idorsia Pharmaceuticals Ltd: Idorsia announces financial results for the full year of 2023 - Adapting the company to create sustainable value - Vimarsana News

Idorsia Pharmaceuticals Ltd: Idorsia announces financial results for the full year of 2023 - Adapting the company to create sustainable value

Ad hoc announcement pursuant to Art. 53 LR Allschwil, Switzerland - May 21, 2024Idorsia Ltd (SIX: IDIA) today announced its financial results for the full year of 2023. Business highlights Sale

Neurocrine scores surprise win with depression drug - Vimarsana News

Neurocrine scores surprise win with depression drug

BioPharma

World Orphan Drug Alliance Expands to Japan & South Korea and the African Subcontinent - Vimarsana News

World Orphan Drug Alliance Expands to Japan & South Korea and the African Subcontinent

Japan, South Korea, and the African subcontinent are now covered by the Alliance. With the addition of two new WODA members – Nxera Pharma (formerly Sosei Heptares) and Veld Pharmaceuticals – WODA now provides access to over 200 million rare disease patients. TOKYO and ZUG, Switzerland, April 08, 2024 (GLOBE NEWSWIRE) -- The World Orphan Drug Alliance (WODA), a global alliance of commercial distributors dedicated to providing access to treatments for rare diseases and specialty medicines in comp

Source: yahoo.com